Last quarter (Q4 2023), Pharming Group's total revenue was €―, a decrease of -100.00% from the same quarter last year. In Q4, Pharming Group's net income was €―. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	€ 104.38M	€ 245.32M	€ 205.62M	€ 198.87M	€ 172.51M	€ 169.02M
Cost of Revenue	€ 6.41M	€ 25.21M	€ -17.56M	€ -21.14M	€ 23.54M	€ 21.36M
Gross Profit	€ 97.97M	€ 220.10M	€ 188.06M	€ 177.73M	€ 188.63M	€ 147.67M
Operating Expense	€ 72.39M	€ 244.18M	€ 184.30M	€ 166.80M	€ 112.38M	€ 86.76M
Operating Income	€ 25.59M	€ -24.07M	€ 3.76M	€ 10.93M	€ 62.00M	€ 60.91M
Net Non Operating Interest Income Expense	€ 3.47M	€ -2.44M	€ -978.00K	€ 8.71M	€ -5.30M	€ -10.91M
Other Income Expense	€ -219.00K	€ -17.47M	€ -12.26M	€ -3.41M	€ -26.86M	€ -3.32M
Pretax Income	€ 28.84M	€ -12.01M	€ 14.99M	€ 23.08M	€ 35.85M	€ 46.68M
Tax Provision	€ 3.99M	€ -1.46M	€ 1.31M	€ 7.08M	€ 6.35M	€ 10.48M
Earnings From Equity Interest Net Of Tax	-	€ -289.00K	€ -1.08M	€ 694.00K	-	-
Net Income Common Stockholders	€ 24.84M	€ -10.55M	€ 13.72M	€ 15.96M	€ 37.75M	€ 36.20M
Basic EPS	-	€ -0.02	€ 0.02	€ 0.03	€ 0.51	€ 0.58
Diluted EPS	-	€ -0.01	€ 0.02	€ 0.02	€ 0.48	€ 0.54
Basic Average Shares	-	€ 657.02M	€ 648.68M	€ 642.01M	€ 63.63M	€ 62.63M
Diluted Average Shares	-	€ 725.46M	€ 686.20M	€ 798.20M	€ 68.27M	€ 67.35M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	€ 78.80M	€ 269.39M	€ 166.74M	€ 145.66M	€ 135.92M	€ 108.11M
Net Income From Continuing And Discontinued Operation	€ 24.84M	€ -10.55M	€ 13.72M	€ 15.96M	€ 37.75M	€ 36.20M
Normalized Income	€ 24.84M	-	-	-	€ 49.63M	€ 38.95M
Interest Expense	€ 2.60M	-	-	-	€ 5.94M	€ 11.92M
EBIT	€ 31.43M	-	€ 11.04M	€ 18.63M	€ 50.04M	€ 58.60M
EBITDA	€ 35.46M	-	€ 24.22M	€ 38.24M	€ 58.35M	€ 63.77M

Currency in EUR

Pharming Group Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing